Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Action inhibitors, enhancers |
Mechanism APP inhibitors(Beta amyloid A4 protein inhibitors), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H22FNO2 |
InChIKeyMIAAEZHCLGEOTC-XUZJFQRFSA-N |
CAS Registry902143-24-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | United States | 22 Sep 2005 |